Elizabeth Gordon

Elizabeth joined Qynapse in 2021 as a Senior Clinical Scientist and now serves as the Scientific Director leading the clinical scientific program. She brings with her over 15 years of experience in neuroscience and quantitative image analysis in neurodegenerative dementia clinical trials and Central Nervous System (CNS) disorders.

Prior to joining Qynapse, Elizabeth led the imaging clinical trials unit at the Institute of Neurology, UCL in Queens Square, London alongside supporting a wide portfolio of research projects within the Dementia Research Centre, UCL.

Elizabeth earned her MSc in Clinical and Experimental Medicine and PhD in neuroscience from UCL, focusing on the use of longitudinal neuroimaging to improve differential diagnosis and track disease progression across the dementias with a view to develop imaging biomarkers for dementia clinical trials.

With a strong clinical operations and scientific background, Elizabeth is keen to drive Qynapse's neuroimaging and prognostic solutions to reach an ever growing healthcare and clinical trial market to support improved assessments for CNS patients across all points of contact they may have in their clinical journey.